This study did not evaluate other exocrine biomarkers previously identified as abnormal in pre-clinical T1D, including fecal elastase, serum carboxypeptidase A1 and chymotrypsinogen B1, and pancreas volume by MRI (7–11, 14, 15). This evidence concerns the gene CTRB1 and type 1 diabetes mellitus.